Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 10.71 USD 0.66% Market Closed
Market Cap: 452m USD
Have any thoughts about
Urogen Pharma Ltd?
Write Note

P/OCF
Price to OCF

-4.7
Current
-3.7
Median
21.9
Industry
Lower than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-4.7
=
Market Cap
449.3m USD
/
Operating Cash Flow
-96.1m USD
All Countries
Close
Market Cap P/OCF
IL
Urogen Pharma Ltd
NASDAQ:URGN
449.3m USD -4.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -239 690.7
US
Abbvie Inc
NYSE:ABBV
315.2B USD 19.1
US
Amgen Inc
NASDAQ:AMGN
141.9B USD 19.6
US
Gilead Sciences Inc
NASDAQ:GILD
116.4B USD 11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
104.5B USD -124
US
Epizyme Inc
F:EPE
94.1B EUR -469.3
AU
CSL Ltd
ASX:CSL
135.7B AUD 30.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.7B USD 18.5
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
36B EUR -144.3
 
IL
Urogen Pharma Ltd
NASDAQ:URGN
Average P/OCF: 19.9
Negative Multiple: -4.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -239 690.7
US
Abbvie Inc
NYSE:ABBV
19.1
US
Amgen Inc
NASDAQ:AMGN
19.6
US
Gilead Sciences Inc
NASDAQ:GILD
11.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -124
US
E
Epizyme Inc
F:EPE
Negative Multiple: -469.3
AU
CSL Ltd
ASX:CSL
30.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.5
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -144.3

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More